nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralatrexate—FPGS—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.0868	0.124	CbGpPWpGaD
Pralatrexate—DHFR—Nucleotide Metabolism—RRM1—adrenal gland cancer	0.0564	0.0806	CbGpPWpGaD
Pralatrexate—SLC19A1—gonad—adrenal gland cancer	0.0396	0.132	CbGeAlD
Pralatrexate—DHFR—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.0363	0.0518	CbGpPWpGaD
Pralatrexate—SLC19A1—adrenal gland—adrenal gland cancer	0.0345	0.115	CbGeAlD
Pralatrexate—FPGS—adrenal cortex—adrenal gland cancer	0.0319	0.106	CbGeAlD
Pralatrexate—TYMS—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.0316	0.0452	CbGpPWpGaD
Pralatrexate—FPGS—cardiac atrium—adrenal gland cancer	0.0264	0.0878	CbGeAlD
Pralatrexate—FPGS—pituitary gland—adrenal gland cancer	0.0257	0.0858	CbGeAlD
Pralatrexate—FPGS—adrenal gland—adrenal gland cancer	0.023	0.0766	CbGeAlD
Pralatrexate—DHFR—adrenal cortex—adrenal gland cancer	0.0207	0.0689	CbGeAlD
Pralatrexate—TYMS—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.0201	0.0288	CbGpPWpGaD
Pralatrexate—DHFR—E2F transcription factor network—RRM1—adrenal gland cancer	0.0192	0.0275	CbGpPWpGaD
Pralatrexate—TYMS—gonad—adrenal gland cancer	0.0173	0.0577	CbGeAlD
Pralatrexate—DHFR—gonad—adrenal gland cancer	0.0171	0.0571	CbGeAlD
Pralatrexate—DHFR—cardiac atrium—adrenal gland cancer	0.0171	0.057	CbGeAlD
Pralatrexate—TYMS—E2F transcription factor network—RRM1—adrenal gland cancer	0.0168	0.024	CbGpPWpGaD
Pralatrexate—DHFR—pituitary gland—adrenal gland cancer	0.0167	0.0557	CbGeAlD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—RRM1—adrenal gland cancer	0.0167	0.0239	CbGpPWpGaD
Pralatrexate—TYMS—Nucleotide metabolism—RRM1—adrenal gland cancer	0.0159	0.0227	CbGpPWpGaD
Pralatrexate—TYMS—adrenal gland—adrenal gland cancer	0.0151	0.0503	CbGeAlD
Pralatrexate—DHFR—adrenal gland—adrenal gland cancer	0.0149	0.0498	CbGeAlD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—RRM1—adrenal gland cancer	0.0146	0.0208	CbGpPWpGaD
Pralatrexate—FPGS—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.0122	0.0175	CbGpPWpGaD
Pralatrexate—SLC19A1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—adrenal gland cancer	0.0111	0.0159	CbGpPWpGaD
Pralatrexate—DHFR—E2F mediated regulation of DNA replication—RB1—adrenal gland cancer	0.0104	0.0149	CbGpPWpGaD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—TOP2A—adrenal gland cancer	0.0103	0.0147	CbGpPWpGaD
Pralatrexate—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—adrenal gland cancer	0.00946	0.0135	CbGpPWpGaD
Pralatrexate—TYMS—E2F mediated regulation of DNA replication—RB1—adrenal gland cancer	0.00912	0.013	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—TOP2A—adrenal gland cancer	0.009	0.0129	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.00836	0.0119	CbGpPWpGaD
Pralatrexate—SLC19A1—Folate Metabolism—TP53—adrenal gland cancer	0.00826	0.0118	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.00777	0.0111	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—SH3KBP1—adrenal gland cancer	0.00734	0.0105	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—TOP2A—adrenal gland cancer	0.00726	0.0104	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—SDHB—adrenal gland cancer	0.00723	0.0103	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—ZNRF3—adrenal gland cancer	0.0069	0.00987	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—TOP2A—adrenal gland cancer	0.00633	0.00905	CbGpPWpGaD
Pralatrexate—FPGS—Disease—SH3KBP1—adrenal gland cancer	0.00624	0.00892	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—SDHB—adrenal gland cancer	0.00615	0.00879	CbGpPWpGaD
Pralatrexate—FPGS—Disease—ZNRF3—adrenal gland cancer	0.00587	0.00839	CbGpPWpGaD
Pralatrexate—DHFR—E2F transcription factor network—RB1—adrenal gland cancer	0.00554	0.00791	CbGpPWpGaD
Pralatrexate—DHFR—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.00511	0.0073	CbGpPWpGaD
Pralatrexate—DHFR—E2F transcription factor network—CDKN2A—adrenal gland cancer	0.00487	0.00695	CbGpPWpGaD
Pralatrexate—TYMS—E2F transcription factor network—RB1—adrenal gland cancer	0.00483	0.0069	CbGpPWpGaD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—RB1—adrenal gland cancer	0.00481	0.00687	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.0048	0.00686	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—SDHD—adrenal gland cancer	0.00466	0.00666	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—RRM1—adrenal gland cancer	0.00466	0.00666	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00461	0.00658	CbGpPWpGaD
Pralatrexate—TYMS—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.00446	0.00637	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—SPRY2—adrenal gland cancer	0.00433	0.00618	CbGpPWpGaD
Pralatrexate—TYMS—E2F transcription factor network—CDKN2A—adrenal gland cancer	0.00425	0.00607	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—RB1—adrenal gland cancer	0.0042	0.006	CbGpPWpGaD
Pralatrexate—DHFR—G1/S Transition—RB1—adrenal gland cancer	0.00402	0.00574	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—MEN1—adrenal gland cancer	0.00397	0.00567	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—RRM1—adrenal gland cancer	0.00396	0.00566	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—SDHD—adrenal gland cancer	0.00396	0.00566	CbGpPWpGaD
Pralatrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—adrenal gland cancer	0.00395	0.00565	CbGpPWpGaD
Pralatrexate—FPGS—Disease—SPRY2—adrenal gland cancer	0.00368	0.00526	CbGpPWpGaD
Pralatrexate—TYMS—G1/S Transition—RB1—adrenal gland cancer	0.0035	0.00501	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—MED12—adrenal gland cancer	0.00348	0.00497	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—RB1—adrenal gland cancer	0.00338	0.00484	CbGpPWpGaD
Pralatrexate—FPGS—Disease—MEN1—adrenal gland cancer	0.00337	0.00482	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.00336	0.0048	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PRKACA—adrenal gland cancer	0.00303	0.00433	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—CDKN2A—adrenal gland cancer	0.00298	0.00425	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—MED12—adrenal gland cancer	0.00295	0.00422	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—RB1—adrenal gland cancer	0.00295	0.00422	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—TP53—adrenal gland cancer	0.00294	0.00419	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	0.00266	0.0038	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SH3KBP1—adrenal gland cancer	0.00261	0.00373	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—CDKN2A—adrenal gland cancer	0.0026	0.00371	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PRKACA—adrenal gland cancer	0.00257	0.00368	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—SDHB—adrenal gland cancer	0.00257	0.00367	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CDC42—adrenal gland cancer	0.00257	0.00367	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PRKACA—adrenal gland cancer	0.00254	0.00362	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.0025	0.00357	CbGpPWpGaD
Pralatrexate—DHFR—Disease—ZNRF3—adrenal gland cancer	0.00245	0.0035	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TOP2A—adrenal gland cancer	0.00238	0.0034	CbGpPWpGaD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	0.00235	0.00336	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	0.00234	0.00335	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	0.00232	0.00332	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SDHB—adrenal gland cancer	0.00224	0.0032	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CDC42—adrenal gland cancer	0.00218	0.00312	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PRKACA—adrenal gland cancer	0.00216	0.00308	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—PRKACA—adrenal gland cancer	0.0021	0.00299	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TOP2A—adrenal gland cancer	0.00208	0.00297	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—TERT—adrenal gland cancer	0.00206	0.00294	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—GNAS—adrenal gland cancer	0.00205	0.00294	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	0.00205	0.00293	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	0.00205	0.00292	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—ABCB1—adrenal gland cancer	0.00202	0.00288	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.00184	0.00263	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—PRKACA—adrenal gland cancer	0.00183	0.00261	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—BAD—adrenal gland cancer	0.00179	0.00256	CbGpPWpGaD
Pralatrexate—FPGS—Disease—TERT—adrenal gland cancer	0.00175	0.0025	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—GNAS—adrenal gland cancer	0.00175	0.0025	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ABCB1—adrenal gland cancer	0.00171	0.00245	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—RRM1—adrenal gland cancer	0.00166	0.00237	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—SDHD—adrenal gland cancer	0.00166	0.00237	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.00165	0.00235	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—BRAF—adrenal gland cancer	0.00163	0.00233	CbGpPWpGaD
Pralatrexate—DHFR—Disease—SPRY2—adrenal gland cancer	0.00154	0.0022	CbGpPWpGaD
Pralatrexate—FPGS—Disease—BAD—adrenal gland cancer	0.00152	0.00218	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—RRM1—adrenal gland cancer	0.00144	0.00206	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—SDHD—adrenal gland cancer	0.00144	0.00206	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TERT—adrenal gland cancer	0.00143	0.00204	CbGpPWpGaD
Pralatrexate—DHFR—Disease—MEN1—adrenal gland cancer	0.00141	0.00201	CbGpPWpGaD
Pralatrexate—FPGS—Disease—BRAF—adrenal gland cancer	0.00139	0.00198	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—POMC—adrenal gland cancer	0.00138	0.00198	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PTGS2—adrenal gland cancer	0.00132	0.00188	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.0013	0.00186	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TERT—adrenal gland cancer	0.00124	0.00178	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—RB1—adrenal gland cancer	0.00124	0.00177	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—MED12—adrenal gland cancer	0.00123	0.00176	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CTNNB1—adrenal gland cancer	0.00118	0.00168	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—POMC—adrenal gland cancer	0.00118	0.00168	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PTGS2—adrenal gland cancer	0.00112	0.0016	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—RB1—adrenal gland cancer	0.00111	0.00159	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PTGS2—adrenal gland cancer	0.0011	0.00158	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.00109	0.00156	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	0.00109	0.00156	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—RB1—adrenal gland cancer	0.00108	0.00155	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—MED12—adrenal gland cancer	0.00108	0.00154	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PRKACA—adrenal gland cancer	0.00108	0.00154	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—TP53—adrenal gland cancer	0.00105	0.0015	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CTNNB1—adrenal gland cancer	0.001	0.00143	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN2A—adrenal gland cancer	0.000976	0.00139	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—RB1—adrenal gland cancer	0.000969	0.00138	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	0.000952	0.00136	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PTGS2—adrenal gland cancer	0.000938	0.00134	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—EGFR—adrenal gland cancer	0.000934	0.00133	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDC42—adrenal gland cancer	0.000912	0.0013	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PRKACA—adrenal gland cancer	0.0009	0.00129	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN2A—adrenal gland cancer	0.000851	0.00122	CbGpPWpGaD
Pralatrexate—FPGS—Disease—EGFR—adrenal gland cancer	0.000794	0.00113	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PRKACA—adrenal gland cancer	0.000786	0.00112	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TERT—adrenal gland cancer	0.000732	0.00105	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—GNAS—adrenal gland cancer	0.00073	0.00104	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ABCB1—adrenal gland cancer	0.000716	0.00102	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—GNAS—adrenal gland cancer	0.000637	0.00091	CbGpPWpGaD
Pralatrexate—DHFR—Disease—BAD—adrenal gland cancer	0.000636	0.000909	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ABCB1—adrenal gland cancer	0.000625	0.000893	CbGpPWpGaD
Pralatrexate—DHFR—Disease—BRAF—adrenal gland cancer	0.000579	0.000828	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—TP53—adrenal gland cancer	0.000543	0.000776	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—POMC—adrenal gland cancer	0.000491	0.000702	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—TP53—adrenal gland cancer	0.000474	0.000677	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PTGS2—adrenal gland cancer	0.000468	0.000669	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—POMC—adrenal gland cancer	0.000429	0.000613	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CTNNB1—adrenal gland cancer	0.000419	0.000598	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PTGS2—adrenal gland cancer	0.000392	0.00056	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PTGS2—adrenal gland cancer	0.000342	0.000489	CbGpPWpGaD
Pralatrexate—DHFR—Disease—EGFR—adrenal gland cancer	0.000332	0.000474	CbGpPWpGaD
